PTTG1
PTTG1, also known as securin, PTTG, HPTTG, EAP1, ECRAR and TUTR1, is a regulatory protein that restrains sister chromatid separation during mitosis. It also influences the p53/TP53 pathway and DNA repair, and is highly expressed in various tumours. Browse Assay Genie's current range of PTTG1 research reagents below, or read on for the biology behind the target.
PTTG1 is a regulatory protein with a central role in chromosome stability, the p53/TP53 pathway and DNA repair. During mitosis it blocks Separase (ESPL1) function, preventing proteolysis of the cohesin complex and so the segregation of chromosomes. At the onset of anaphase PTTG1 is ubiquitinated and destroyed, which liberates ESPL1. Its role is not limited to inhibition, since it is also required to activate ESPL1.
The PTTG1 protein is a homolog of yeast securin proteins, which prevent separins from promoting sister chromatid separation, and belongs to the securin family. It is a substrate of the anaphase-promoting complex (APC) and associates with a separin until the APC is activated. A destruction box (D box) is required for its degradation by the APC. The protein also contains two PXXP motifs, which are needed for its transforming and tumorigenic activities and for its stimulation of basic fibroblast growth factor expression, and an acidic C-terminal region that can act as a transactivation domain. PTTG1 is mainly cytosolic, although it partially localises to the nucleus. Three transcript variants of the PTTG1 gene encode the same protein.
PTTG1 negatively regulates the transcriptional activity and related apoptosis activity of TP53, which may explain its strong transforming capability when overexpressed. The protein has transforming activity in vitro and tumorigenic activity in vivo, and the gene is highly expressed in various tumours. Through its interaction with Ku, PTTG1 may also connect DNA damage-response pathways with sister chromatid separation. The earlier name, pituitary tumour-transforming 1, reflects this transforming activity.
PTTG1 blocks Separase/ESPL1 and the proteolysis of cohesin until anaphase, making it a key factor in sister chromatid separation.
PTTG1 has transforming activity in vitro and tumorigenic activity in vivo, and the gene is highly expressed in various tumours.
PTTG1 negatively regulates the transcriptional and apoptotic activity of TP53, linking overexpression to transformation.
Through its interaction with Ku, PTTG1 may connect DNA damage-response pathways with sister chromatid separation.
PTTG1, or securin, blocks Separase/ESPL1 during mitosis, preventing cohesin proteolysis and chromosome segregation. At anaphase onset it is ubiquitinated and destroyed, releasing ESPL1. It is also required to activate ESPL1, and it negatively regulates TP53 transcriptional and apoptotic activity.
PTTG1 is also called securin, PTTG, HPTTG, EAP1, ECRAR and TUTR1. The previous name was pituitary tumour-transforming 1. Three transcript variants of the gene have been found, and all encode the same protein.
The PTTG1 gene is highly expressed in various tumours, and the protein has transforming and tumorigenic activity. Mouse and rat both have a Pttg1 ortholog. Check the datasheet of any product for its validated reactivity.
Other PTTG family members and PTTG1-interacting proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O95997; product specifications from Assay Genie datasheets.